Trial intelligence / Profile preview

Oxytocin and Social Skills Training in Schizophrenia

NCT01598623Phase 2Unknown

Sponsor
Sheba Medical Center
Start
May 2012
Primary completion
Feb 2014
Countries
1
01

Overview

A Phase 2 trial of oxytocin nasal spray in schizophrenia, schizoaffective disorder, sponsored by Sheba Medical Center. Status: unknown.

02

Drugs

oxytocin nasal spray
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT01598623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01598623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call